$4.53
0.14 (+3.08%)
Nymox Pharmaceutical Corp (NYMX)
CAPS Rating:
A biopharmaceutical company with three proprietary products on the market and a R&D of drug & diagnostic products in development for the treatment of enlarged prostate, Alzheimer's disease contamination of food and drink products and bacterial infections.

RSS Headlines
Fool UK